Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Besch

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Molecular Genetics and Metabolism|August 23, 2011
Deficient degradation of homotrimeric type I collagen, α1(I)3 glomerulopathy in oim miceAnna M Roberts-Pilgrim, Elena Makareeva, Matthew H Myles, et al.
HIV Clinical Trials|February 1, 2005
Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive personsR D MacArthur, L Chen, G Peng, et al.
Toxicology and Applied Pharmacology|September 10, 2002
Uterine responsiveness to estradiol and DNA methylation are altered by fetal exposure to diethylstilbestrol and methoxychlor in CD-1 mice: effects of low versus high dosesL C Alworth, K L Howdeshell, R L Ruhlen, et al.
Controlled Clinical Trials|April 18, 2001
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trialR D MacArthur, L Chen, D L Mayers, et al.
Journal of Anatomy|December 20, 2008
The role of human beta-defensin-2 in boneD Varoga, M Tohidnezhad, F Paulsen, et al.
Endocrinology|July 4, 2012
Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP miceAnna Slusarz, Glenn A Jackson, J Kevin Day, et al.
The New England Journal of Medicine|July 31, 1997
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDSF M Gordin, J P Matts, C Miller, et al.
Tissue Engineering. Part A|March 13, 2008
Tissue engineering by self-assembly of cells printed into topologically defined structuresKaroly Jakab, Cyrille Norotte, Brook Damon, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 1996
The impact of human immunodeficiency virus infection on drug-resistant tuberculosisF M Gordin, E T Nelson, J P Matts, et al.
Laboratory Animal Science|July 14, 1999
Natural and experimentally induced infection of Syrian hamsters with a newly recognized parvovirusD G Besselsen, S V Gibson, C L Besch-Williford, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Molecular Genetics and Metabolism|August 23, 2011
Deficient degradation of homotrimeric type I collagen, α1(I)3 glomerulopathy in oim miceAnna M Roberts-Pilgrim, Elena Makareeva, Matthew H Myles, et al.
HIV Clinical Trials|February 1, 2005
Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive personsR D MacArthur, L Chen, G Peng, et al.
Toxicology and Applied Pharmacology|September 10, 2002
Uterine responsiveness to estradiol and DNA methylation are altered by fetal exposure to diethylstilbestrol and methoxychlor in CD-1 mice: effects of low versus high dosesL C Alworth, K L Howdeshell, R L Ruhlen, et al.
Controlled Clinical Trials|April 18, 2001
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trialR D MacArthur, L Chen, D L Mayers, et al.
Journal of Anatomy|December 20, 2008
The role of human beta-defensin-2 in boneD Varoga, M Tohidnezhad, F Paulsen, et al.
Endocrinology|July 4, 2012
Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP miceAnna Slusarz, Glenn A Jackson, J Kevin Day, et al.
The New England Journal of Medicine|July 31, 1997
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDSF M Gordin, J P Matts, C Miller, et al.
Tissue Engineering. Part A|March 13, 2008
Tissue engineering by self-assembly of cells printed into topologically defined structuresKaroly Jakab, Cyrille Norotte, Brook Damon, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 1996
The impact of human immunodeficiency virus infection on drug-resistant tuberculosisF M Gordin, E T Nelson, J P Matts, et al.
Laboratory Animal Science|July 14, 1999
Natural and experimentally induced infection of Syrian hamsters with a newly recognized parvovirusD G Besselsen, S V Gibson, C L Besch-Williford, et al.
Pageof 14